ClinicalTrials.Veeva

Menu

Remotely-supervised Neuromodulation in PPA

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Logopenic Variant Primary Progressive Aphasia
Progressive Aphasia
Progressive Aphasia in Alzheimer's Disease
Logopenic Progressive Aphasia (LPA)
Primary Progressive Aphasia(PPA)
Logopenic Variant of Primary Progressive Aphasia (LPA)

Treatments

Device: Remotely Supervised Transcranial Direct Current Stimulation
Behavioral: Lexical Retrieval Cascade Treatment

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07260253
RF1AG085565 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this clinical trial is to learn whether remotely-supervised transcranial direct-current stimulation (RS-tDCS) can improve speech and language treatments for individuals with logopenic variant primary progressive aphasia (lvPPA). tDCS is a form of brain stimulation where a low-level electrical current is delivered to the brain through electrodes placed on the head.

The main questions the trial aims to answer are:

  • Is it feasible to do RS-tDCS with virtual speech therapy?
  • How can brain magnetic resonance imaging scans (MRIs) predict how well someone will benefit from RS-tDCS with virtual speech therapy?

Researchers will compare active RS-tDCS stimulation to sham stimulation (where there is no active stimulation, but participants feel stimulation effects at the beginning and end of the session).

Participants will:

  • Travel to either the University of California, San Francisco (UCSF) or the University of Texas at Austin (UT Austin) one time for in-person testing, an MRI scan, and training on how to use the RS-tDCS equipment
  • Meet with a speech-language pathologist for pre-treatment testing on Zoom for 2 weeks
  • Participate in speech-language therapy and independent practice on Zoom 5 days a week for 4 weeks, using either active tDCS stimulation or sham
  • Complete post-treatment testing on Zoom for 1-2 weeks
  • Complete follow-up testing 2 months after completion of treatment

Enrollment

80 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meets diagnostic criteria for primary progressive aphasia (PPA)
  • Meets diagnostic criteria for logopenic variant PPA
  • Score of 20 or higher on the Mini-Mental State Examination
  • Adequate hearing and vision (with hearing or vision aids, if needed)
  • Has a study partner that can co-enroll in the study and attend pre-treatment training as well as continue to be present for teleconference meetings, as needed
  • Able and willing to undergo MRI brain scan
  • Access to high speed internet and basic experience using a computer and the internet
  • Individuals should be fluent speakers of English

Exclusion criteria

  • Speech and language deficits better accounted for by another neurological disorder
  • Does not meet diagnostic criteria for logopenic variant PPA
  • Score of less than 20 on the Mini-Mental State Examination
  • Does not have a study partner who can co-enroll in the study
  • Contraindications for tDCS or MRI scan (History of seizures, head injury, craniotomy, skull surgery or fracture; History of severe or frequent migraines; Metallic implant in head or any metal in head; Pacemaker or cardioverter-defibrillator or any other stimulator; Chronic skin problems; Pregnancy)
  • History of stroke, epilepsy, or significant brain injury

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

80 participants in 2 patient groups

Language Therapy with Active Stimulation
Experimental group
Description:
Transcranial direct current stimulation (tDCS) is a type of non-invasive brain stimulation. 1.5 milliamp (mA) of current will be delivered via electrodes in saline-soaked sponges placed on the left and right sides of the head. The stimulation will be delivered for 20 minutes, 5 times weekly, in the participant's home setting while the participant engages in virtual speech-language training. Sessions are monitored by study personnel.
Treatment:
Behavioral: Lexical Retrieval Cascade Treatment
Device: Remotely Supervised Transcranial Direct Current Stimulation
Language Therapy with Sham Stimulation
Sham Comparator group
Description:
Transcranial direct current stimulation (tDCS) is a type of non-invasive brain stimulation. During sham stimulation 1.5 milliamp (mA) of current will be delivered for a brief period and then turned off. Current will be delivered via electrodes in saline-soaked sponges placed on the left and right sides of the head. Sham will be delivered for 20 minutes, 5 times weekly, in the participant's home setting while the participant engages in virtual speech-language training. Sessions are monitored by study personnel.
Treatment:
Behavioral: Lexical Retrieval Cascade Treatment
Device: Remotely Supervised Transcranial Direct Current Stimulation

Trial contacts and locations

2

Loading...

Central trial contact

Aphasia Lab Research Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems